相关实验视频

Updated: Jul 20, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

素酸通过抑制ZFP30减轻肝硬化症,从而减轻肝硬化

Han Ding¹, Kunyi Ge¹, Changyu Fan¹

¹School of Life Science, Jiangsu Normal University, Xuzhou, Jiangsu 221116, China.

Journal of agricultural and food chemistry

|December 26, 2023

概括

在非酒精性脂肪肝疾病 (NAFLD) 中,ZFP30蛋白质水平增加. 减少ZFP30有助于脂肪肝,而增加它会使病情恶化,强调ZFP30作为治疗点.

科学领域:

肝病学和分子生物学
代谢障碍研究研究代谢障碍

背景情况:

非酒精性脂肪肝 (NAFLD) 是一个普遍存在的全球健康问题,缺乏经批准的药理疗法.
对于NAFLD干预来说,迫切需要有效的治疗目标.

研究的目的:

调查ZFP30在NAFLD病变发生中的作用.
探索ZFP30作为NAFLD的潜在治疗点.

主要方法:

在NAFLD模型中检查了ZFP30表达.
利用ZFP30沉默和肝细胞过度表达来评估其对脂质积累的影响.
研究了涉及PPARα和KAP1.1的分子机制.
评估了酸 (CGA) 对ZFP30和NAFLD进展的影响.

主要成果:

在NAFLD模型中,ZFP30的表达显著增加.
ZFP30沉默可以改善自由脂肪酸 (FFA) 诱导的脂质积累,而过度表达会加剧它.
ZFP30通过直接结合其促进体和招募KAP1.1,降低了PPARα转录的调节.
酸 (CGA) 逆转了NAFLD中的ZFP30上调,促进了PPARα的表达并增强了脂肪酸的氧化.

结论:

在NAFLD中,ZFP30在促进肝脂积累和肥胖症方面发挥着至关重要的作用.
ZFP30通过抑制PPARα表达而起作用.
ZFP30代表了NAFLD治疗的有前途的治疗标,CGA显示了减轻肝硬化症的潜力.

关键词:

这是一种PPARα.在ZFP30中,ZFP30是原酸是一种原酸.肝脏肥胖症肝脏肥胖症

更多相关视频

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Analysis of Liver Microenvironment During Early Progression of Non-Alcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in Zebrafish

Published on: April 1, 2021

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium

Published on: May 18, 2021

相关概念视频

Chronic Pancreatitis II: Pathophysiology

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...